Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1445551

Cover Image

PUBLISHER: Market Xcel - Markets and Data | PRODUCT CODE: 1445551

Food Allergy Market Assessment, By Allergen Source, By Diagnosis, By Treatment, By End-user, By Region, Opportunities and Forecast, 2017-2031F

PUBLISHED:
PAGES: 240 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel Printable (Single User License)
USD 4500
PDF & Excel Printable (Corporate License)
USD 5700
PDF & Excel Printable (Custom Research License)
USD 8200

Add to Cart

Global food allergy market is projected to witness a CAGR of 5.29% during the forecast period 2024-2031, growing from USD 45.34 billion in 2023 to USD 68.46 billion in 2031. Growth in the global food allergy market is driven by various factors, such as the increasing prevalence of food allergies among the global population and extensive research and development (R&D) activities in the market. The growing pharmaceutical industry, increased investments by public and private organizations to develop efficient drugs, along a favorable regulatory system are the driving factors for global food allergy market. The presence of several top players, new entrances, and collaborative ventures, such as mergers and acquisitions, partnerships, distribution agreements, and frequent new product launches, further accelerates the market growth.

Another crucial market trend includes tremendous efforts, such as granting funds, from governments across the globe to develop advanced treatment options for food allergies. The continuously increasing demand for efficient drugs in the market has also attracted several pharmaceutical companies, leading to the launch of consistent and highly efficient drugs. This is further supported by the implementation of the favorable regulatory framework, which is playing a pivotal role in boosting the market demand. In line with this, there have been increased FDA approvals for drugs to control severe allergic reactions, which, in turn, has improved patient outcomes and created lucrative market opportunities. Moreover, consistent collaboration activities, such as mergers and acquisitions, partnerships, and distribution agreements, between the organizations, consistent innovative product launches by leading players, and innovative new entrances are further propelling the global food allergy market.

For instance, Kitt Medical Limited is a start-up, founded in the year 2023, that provides anaphylaxis kitt, including adrenaline pens and emergency kits, along with unlimited CPD training. The company aims to provide emergency treatment to individuals experiencing anaphylaxis, as well as raise awareness regarding food allergies.

Increasing Prevalence of Food Allergy

There has been a surge in the global prevalence of food allergy, and it is expected that it will continue to rise in the forecasted period as well, due to which allergy communities have considered food allergy as a growing public health problem. For instance, according to an article published in "Pediatric Allergy and Immunology" journal, globally, 10% of the population is affected by food allergy. It is also estimated that approximately 1 in 10 adults and 1 in 12 children are affected by food allergies and this number is likely to increase in the future. The rising number of food sensitivities among the global population leads to adverse effects, such as anaphylaxis and atopic dermatitis, which increases the need for developing highly efficient drugs to manage these life-threatening reactions. To meet this possible growing demand for food allergy medical solutions, there has been an increase in R&D activities by public and private organizations, which, in turn, is increasing the market demand. Moreover, several pharmaceutical companies are consistently developing and launching drugs to treat the symptoms and reactions of food allergy, thus propelling the global food allergy market.

Increased Research and Development Activities

With the growing demand for food allergy treatment options, there have been increased R&D activities in the market to develop safe, efficient, and economical therapeutical drugs. With the increasing prevalence of food allergies, there is a strong emphasis on improving the understanding of these allergies to help engineer the best practices for allergen control and management. For instance, according to a comprehensive review of food allergy related studies published between 2021 and 2023 in the "Journal of Allergy and Clinical Immunology", it is stated that through consistent research, a new test known as "The basophil activation test (BAT)" has been developed that has shown promising results during the clinical practice. It is a flow cytometry-based test that is highly accurate and efficient in predicting the severity of allergic reactions. This article further elaborates that other research activities are also under process to develop and discover new drugs and vaccines that can help relieve adverse effects of food allergies and enhance tolerance towards these allergies. Due to these frequent R&D activities, the global food allergy market is expected to flourish in the future.

Increased Prevalence of Peanut Allergies

Among the allergen source segment, allergies from peanuts are the most common source of food allergies. As the prevalence of peanut allergies is increasing, the key players are undertaking proficient R&D initiatives to launch individual allergen immunotherapies, which can improve the immunity of the individual towards a certain dose of peanut. For instance, in the year 2023, "Volcani Institute" under Israel National Agricultural Research and Development Center announced the development of Kidon's solution, which is a specialized variety of peanuts that is baked into a cookie to treat children with peanut allergies. This peanut reduces the allergenicity of peanut once it is baked. This solution has been successful in Israel and now the institute intends to request approval in USA and Europe. These innovative discoveries and product launches are propelling the global food allergy market.

Growing Demand for Skin-prick Tests

Among the diagnosis segment, skin-prick tests are widely used because of their high sensitivity and specificity in detecting food allergies. Blood tests for detecting food allergies give results in a day or two, whereas skin-prick tests can be performed immediately by the healthcare provider and hence reduce the waiting time. For instance, according to an article published in "Clinical and Translational Allergy Journal" in February 2023, skin-prick test is the most common and favorable diagnosis technique used by healthcare providers, as it is easy, quick, and gives accurate and immediate results. As this test provides results in just 15 minutes, it eliminates the need for re-scheduling the next appointment to discuss the results with the patients, due to which it is highly accepted among healthcare providers as well as patients. As the prevalence of food allergies is on the rise, there is an increased demand for skin-prick test kits in the market, which is further propelling the global food allergy market.

North America Holds Significant Market Share

North America holds the largest share in the global food allergy market due to the high prevalence of food allergies among adults and children in the United States, the presence of major players, such as Immunomic Therapeutics Inc. and Thermo Fisher Scientific, and increased investments by leading players in developing potential drugs. Additionally, favorable laws regarding the approval of safe and efficient drugs are also leading to market growth in this region. For instance, Novartis, a leading pharmaceutical company announced that it has received FDA approval for its latest drug "Xolair (omalizumab)" for treating and reducing the impact of allergic reactions, such as anaphylaxis. Xolair is so far the only FDA-approved medicine that works efficiently in treating people with one or more food allergies. For now, Xolair is widely available in the United States market, however, it will soon be available in other regions as well. Due to these factors, North America will further show tremendous growth in the food allergy market and will maintain its leadership position during the forecasted period as well.

Future Market Scenario (2024 - 2031F)

The global food allergy market is expected to grow in the future primarily due to the increasing prevalence of food allergies among the population, which has increased leading companies' focus in developing safe and effective drugs that can provide quick relief from allergic reactions. Additionally, there has been a surge in R&D activities by government bodies and other related private firms in the market to further discover the best treatment options for the patients, which, in turn, is anticipated to expand the market size. For instance, "Food Allergy Research & Education", which is a prominent patient advocacy organization for food allergies, as well as the largest private sponsor of food allergy research in the US, is expected to revolutionize the food allergy landscape by granting a fund of USD 3 million to accelerate the R&D activities in the food allergy market. This investment is expected to bring innovation and advancement in the diagnostic aspect and efficient drug developments. Due to these factors, the food allergy market is expected to grow significantly during the forecasted period.

Key Players Landscape and Outlook

In the food allergy market, several pharmaceutical and biotechnological companies are frequently establishing strategic partnerships and distribution agreements, which play a crucial role in the growth of the market. These partnerships enable companies to gain informative insights regarding the market, access each other's resources, markets, and technologies, and invest in R&D activities to bring safe and efficient drugs to the market. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative initiatives promote innovation, and expertise in product development, and contribute to the enduring and robust growth of the market. For instance, in September 2023, Nestle announced that it has divested its peanut allergy treatment business "Palforzia", to Stallergenes Greer, which is a biopharmaceutical company that is highly efficient in the diagnosis and treatment of allergies. This venture aims to bring innovative treatment and diagnostics products to improve the quality of medical treatment for food allergies for the global population.

Product Code: MX11100

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Food Allergy Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Allergen Source
    • 4.2.1. Gluten
    • 4.2.2. Peanut
    • 4.2.3. Mustard
    • 4.2.4. Milk
    • 4.2.5. Egg
    • 4.2.6. Fish
    • 4.2.7. Others
  • 4.3. By Diagnosis
    • 4.3.1. Blood Test
    • 4.3.2. Skin-prick Tests
    • 4.3.3. Others
  • 4.4. By Treatment
    • 4.4.1. Antihistamines
    • 4.4.2. Adrenaline
    • 4.4.3. Oral Immunotherapy
    • 4.4.4. Others
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Specialty Clinics
    • 4.5.3. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Food Allergy Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Allergen Source
      • 5.1.2.1. Gluten
      • 5.1.2.2. Peanut
      • 5.1.2.3. Mustard
      • 5.1.2.4. Milk
      • 5.1.2.5. Egg
      • 5.1.2.6. Fish
      • 5.1.2.7. Others
    • 5.1.3. By Diagnosis
      • 5.1.3.1. Blood Test
      • 5.1.3.2. Skin-prick Tests
      • 5.1.3.3. Others
    • 5.1.4. By Treatment
      • 5.1.4.1. Antihistamines
      • 5.1.4.2. Adrenaline
      • 5.1.4.3. Oral Immunotherapy
      • 5.1.4.4. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Specialty Clinics
      • 5.1.5.3. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
      • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Allergen Source
      • 5.1.6.2.1. Gluten
      • 5.1.6.2.2. Peanut
      • 5.1.6.2.3. Mustard
      • 5.1.6.2.4. Milk
      • 5.1.6.2.5. Egg
      • 5.1.6.2.6. Fish
      • 5.1.6.2.7. Others
      • 5.1.6.3. By Diagnosis
      • 5.1.6.3.1. Blood Test
      • 5.1.6.3.2. Skin-prick Tests
      • 5.1.6.3.3. Others
      • 5.1.6.4. By Treatment
      • 5.1.6.4.1. Antihistamines
      • 5.1.6.4.2. Adrenaline
      • 5.1.6.4.3. Oral Immunotherapy
      • 5.1.6.4.4. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Specialty Clinics
      • 5.1.6.5.3. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Allergen Source
  • 6.2. By Diagnosis
  • 6.3. By Treatment
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Allergy Therapeutics PLC
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Immunomic Therapeutics Inc.
  • 13.3. Prota Therapeutics Pty Ltd.
  • 13.4. Aimmune Therapeutics UK Limited (Nestle S.A)
  • 13.5. Thermo Fisher Scientific
  • 13.6. DBV Technologies
  • 13.7. Novartis Pharmaceuticals Corporation
  • 13.8. Vedanta Biosciences, Inc.
  • 13.9. F. Hoffmann-La Roche AG.
  • 13.10. Danaher Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

Product Code: MX11100

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 4. Global Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 5. Global Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 6. Global Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Food Allergy Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 11. North America Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 12. North America Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 13. North America Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Food Allergy Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 18. United States Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 19. United States Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 20. United States Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 24. Canada Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 25. Canada Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 26. Canada Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 30. Mexico Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 31. Mexico Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 32. Mexico Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 36. Europe Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 37. Europe Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 38. Europe Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Food Allergy Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 43. Germany Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 44. Germany Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 45. Germany Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 49. France Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 50. France Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 51. France Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 55. Italy Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 56. Italy Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 57. Italy Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 61. United Kingdom Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 62. United Kingdom Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 63. United Kingdom Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 67. Russia Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 68. Russia Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 69. Russia Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 73. Netherlands Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 74. Netherlands Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 75. Netherlands Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 79. Spain Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 80. Spain Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 81. Spain Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 85. Turkey Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 86. Turkey Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 87. Turkey Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 91. Poland Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 92. Poland Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 93. Poland Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 97. South America Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 98. South America Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 99. South America Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Food Allergy Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 104. Brazil Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 105. Brazil Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 106. Brazil Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 110. Argentina Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 111. Argentina Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 112. Argentina Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 116. Asia-Pacific Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 117. Asia-Pacific Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 118. Asia-Pacific Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Food Allergy Market Share (%), By Country, 2017-2031F
  • Figure 120. India Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 123. India Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 124. India Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 125. India Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 129. China Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 130. China Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 131. China Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 135. Japan Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 136. Japan Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 137. Japan Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 141. Australia Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 142. Australia Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 143. Australia Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 147. Vietnam Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 148. Vietnam Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 149. Vietnam Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 153. South Korea Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 154. South Korea Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 155. South Korea Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 159. Indonesia Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 160. Indonesia Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 161. Indonesia Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 165. Philippines Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 166. Philippines Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 167. Philippines Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 171. Middle East & Africa Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 172. Middle East & Africa Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 173. Middle East & Africa Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Food Allergy Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 178. Saudi Arabia Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 179. Saudi Arabia Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 180. Saudi Arabia Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 184. UAE Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 185. UAE Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 186. UAE Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Food Allergy Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Food Allergy Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Food Allergy Market Share (%), By Allergen Source, 2017-2031F
  • Figure 190. South Africa Food Allergy Market Share (%), By Diagnosis, 2017-2031F
  • Figure 191. South Africa Food Allergy Market Share (%), By Treatment, 2017-2031F
  • Figure 192. South Africa Food Allergy Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Allergen Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Diagnosis Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Treatment Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!